7470-09-9

Basic information

• Product Name: (1Z)-1-[(hydroxyamino)methylidene]naphthalen-2-one
• Synonyms: (1Z)-1-[(hydroxyamino)methylidene]naphthalen-2-one;2-Hydroxy-1-naphthalenecarbaldehyde oxime;2-Hydroxy-1-naphthaldehyde oxime
• CAS NO: 7470-09-9
• Molecular Formula: C₁₁H₉NO₂
• Molecular Weight: 187.19
• Mol File: 7470-09-9.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 423°C at 760 mmHg
• Flash Point: 209.6°C
• Appearance: /
• Density: 1.406g/cm³
• Vapor Pressure: 6.53E-08mmHg at 25°C
• Refractive Index: 1.748
• CAS DataBase Reference: (1Z)-1-[(hydroxyamino)methylidene]naphthalen-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (1Z)-1-[(hydroxyamino)methylidene]naphthalen-2-one(7470-09-9)
• EPA Substance Registry System: (1Z)-1-[(hydroxyamino)methylidene]naphthalen-2-one(7470-09-9)

Safety Data

• Hazardous Substances Data: 7470-09-9(Hazardous Substances Data)

Usage

General Description

"(1Z)-1-[(hydroxyamino)methylidene]naphthalen-2-one" is a chemical compound with the molecular formula C13H9NO2. It is also known as warfarin aldehyde and is a derivative of naphthalen-2-one. (1Z)-1-[(hydroxyamino)methylidene]naphthalen-2-one has a keto-enol tautomerism and exists as a yellow solid. It is a key intermediate in the synthesis of warfarin, which is an anticoagulant medication. The hydroxyamino group in the compound makes it a versatile building block for the synthesis of many other organic compounds, making it important in organic chemistry and pharmaceutical research.

InChI:InChI=1/C11H9NO2/c13-11-6-5-8-3-1-2-4-9(8)10(11)7-12-14/h1-7,12,14H/b10-7-

Upstream product

• 708-06-5 2-hydroxynaphthalene-1-carbaldehyde 
• 135-19-3 β-naphthol 

Downstream Products

• 6333-07-9 1-benzoyl-2-naphthol 
• 872799-22-9 (2-hydroxy-[1]naphthyl)-phenyl ketone-imine 
• 261356-07-4 Ru(P(C₆H₅)3)2(C₁₁H₇NO)Cl₂ 
• 650636-40-1 2-benzoyl-1-aminonaphtho[2,1-b]furan 
• 708-06-5 2-hydroxynaphthalene-1-carbaldehyde 
• 1277186-31-8 C₂₀H₁₆N₄O₂S 
• 1277186-32-9 C₂₁H₁₈N₄O₂S 
• 1277186-33-0 C₂₁H₁₈N₄O₃S 
• 1277186-34-1 C₂₀H₁₅BrN₄O₂S 
• 1277186-35-2 C₂₀H₁₅ClN₄O₂S 
• 1277186-36-3 C₂₀H₁₄N₄O₂ 
• 1277186-37-4 C₂₁H₁₆N₄O₂ 
• 1277186-38-5 C₂₁H₁₆N₄O₃ 
• 1277186-39-6 C₂₀H₁₃BrN₄O₂ 

Relevant articles and documents

A catalytic regioselective procedure for the synthesis of aryl oximes in the presence of palladium nanoparticles

The synthesis of aryl oximes from aryl aldehyde derivatives was carried out using hydroxylamine hydrochloride and aluminum oxy hydroxide-supported palladium (Pd/AlO(OH) nanoparticles. The procedure is revealed via the regioselective synthesis of oxime der

SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX

Compositions and methods for treating thrombosis, inflammation, and atherosclerosis by administration of a compound that binds to KRIT1 to inhibit binding with HEG1.

Calculation and experimental measurement of paramagnetic NMR parameters of phenolic oximate Cu(II) complexes

We present a strategy for predicting the unusual 1H and 13C shifts in NMR spectra of paramagnetic bisoximato copper(ii) complexes using DFT. We demonstrate good agreement with experimental measurements, although 1H-13C correlation spectra show that a combined experimental and theoretical approach remains necessary for full assignment.